z-logo
open-access-imgOpen Access
Combined Interleukin 12 and Granulocyte-macrophage Colony-stimulating Factor Gene Therapy Synergistically Suppresses Tumor Growth in the Murine Fibrosarcoma
Author(s) -
Saiedeh Razi Soofiyani,
Farzaneh Lotfipour,
Tohid Kazemi,
Akbar Mohammad Hoseini,
Dariush Shanehbandi,
Leila Mohammadnejad,
Behzad Baradaran,
Somayeh HallajNezhadi
Publication year - 2017
Publication title -
international journal of cancer management
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.251
H-Index - 19
eISSN - 2538-4422
pISSN - 2538-497X
DOI - 10.5812/ijcm.8462
Subject(s) - fibrosarcoma , granulocyte macrophage colony stimulating factor , lipofectamine , genetic enhancement , immune system , cytokine , interleukin , cancer research , immunohistochemistry , biology , monocyte , transfection , microbiology and biotechnology , medicine , immunology , pathology , cell culture , gene , biochemistry , vector (molecular biology) , recombinant dna , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom